"It is surprising that we still know relatively little regarding whether patients with immune-mediated inflammatory diseases are more or less susceptible to long COVID compared to patients without immune-mediated inflammatory diseases."

"It is surprising that we still know relatively little regarding whether patients with immune-mediated inflammatory diseases are more or less susceptible to long COVID compared to patients without immune-mediated inflammatory diseases." https://www.thelancet.com/journals/lanrhe/home Treating subclinical arthritis: prevention or overtreatment? The Lancet Rheumatology https://www.thelancet.com/journals/lanrhe/issue/current